Indian Immunologicals Limited launches made-in-India Hepatitis A vaccine for children
Hyderabad-based Indian Immunologicals Limited (IIL) announced the launch of the pediatric dose of India’s first indigenous Hepatitis A vaccine, Havisure (0.5 ml)
Hyderabad-based Indian Immunologicals Limited (IIL) announced the launch of the pediatric dose of India’s first indigenous Hepatitis A vaccine, Havisure (0.5 ml)
The State reported 12 deaths due to dengue. Two deaths occurred in Hassan, Dharwad, and Shivamogga each, while Mysuru, Haveri, and Davangere posted one death each.
A recent study examined the challenges faced by disabled, transgender, and gender-diverse communities in India when trying to access Covid-19 vaccines.
Delhi Home Minister Kailash Gahlot inspected the Tihar Jail on Saturday and announced several prison reform steps, including a mental health programme.
The Indonesian government has established mpox screening at I Gusti Ngurah Rai International Airport in Bali in preparation for Indonesia-Africa Forum due on Sept. 1-3
IILa vaccine maker based in Hyderabad, has developed a live-attenuated, needle-free intranasal booster vaccine against SARS-CoV-2 in collaboration with Griffith University
The test has also been “clinically validated by ICMR-National Institute of Virology, Pune”. It boasts an impressive 100 per cent sensitivity and specificity.
An isolation ward, comprising six beds, for people showing the symptoms of monkeypox (mpox) has been set up at the new Government General Hospital in Vijayawada
The Visakhapatnam-based Andhra Pradesh MedTech Zone (AMTZ) on Aug 24 announced a groundbreaking development in diagnostic technology by launching ‘ErbaMDx MonkeyPox RT-PCR Kit’